表紙：トロンビン市場規模、シェア、成長分析、製品別、剤形別、エンドユーザー別、地域別-2025年～2032年産業予測

市場調査レポート

商品コード

1802014

トロンビン市場規模、シェア、成長分析、製品別、剤形別、エンドユーザー別、地域別-2025年～2032年産業予測

Thrombin Market Size, Share, and Growth Analysis, By Product (Bovine Thrombin, Human Thrombin), By Dosage Form (Powder Form, Solution Form), By End-User, By Region - Industry Forecast 2025-2032

出版日: 2025年08月25日
発行: SkyQuest
ページ情報: 英文 173 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 791,025円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 925,350円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,059,675円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=149.25円

全表示
概要
目次

概要

サンプル依頼リストに入れる

トロンビンの世界市場規模は、2023年に6億2,840万米ドルと評価され、2024年の6億6,296万米ドルから2032年には10億1,744万米ドルに成長し、予測期間（2025年～2032年）のCAGRは5.5％で成長する見通しです。

トロンビン市場は、特に外科手術や外傷の場面で、止血や血液凝固に重要な役割を果たすことで顕著な成長を遂げています。心臓血管外科や整形外科を含む外科手術の増加や、より充実した医療を求める高齢化人口の増加が主な成長要因です。組換え型トロンビンのような技術革新により安全性と有効性が改善され、動物由来製品に関する懸念に対処しています。さらに、トロンビンの再生医療や創傷治癒などのバイオテクノロジーや医薬品への応用が拡大していることも、市場拡大に寄与しています。北米は先進的な医療制度と有利な償還政策により現在この市場を独占しており、次いで欧州が続くが、中国やインドを中心とするアジアの新興市場は大きな成長の可能性を秘めています。しかし、高い製造コスト、厳しい規制、他の止血剤との競合といった課題は、市場拡大のリスクとなっています。

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他の欧州
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
ラテンアメリカ
- ブラジル
- その他のラテンアメリカ
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他の中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2024年）
主な市場企業が採用した戦略
最近の市場動向
企業の市場シェア分析（2024年）
主要企業の企業プロファイル
- 企業の詳細
- 製品ポートフォリオ分析
- 企業のセグメント別シェア分析
- 収益の前年比比較（2022年～2024年）

主要企業プロファイル

Pfizer Inc.
Johnson & Johnson Services Inc.
Baxter International Inc.
Shanghai RAAS Blood Products Co. Ltd.
GE Healthcare
Bayer AG
CSL Behring
Grifols
Hualan Biological Engineering
Haematologic Technologies Inc.
Octapharma AG
Omrix Biopharmaceuticals Ltd.
Japan Blood Products Organization
Mallinckrodt Pharmaceuticals
Mochida Pharmaceutical Co. Ltd.

結論と提言

Product Code: SQMIG35I2440

Global Thrombin Market size was valued at USD 628.4 million in 2023 and is poised to grow from USD 662.96 million in 2024 to USD 1017.44 million by 2032, growing at a CAGR of 5.5% during the forecast period (2025-2032).

The thrombin market is experiencing notable growth, driven by its critical role in hemostasis and blood coagulation, particularly in surgical and trauma settings. Increasing surgical procedures, including cardiovascular and orthopedic surgeries, alongside a growing aging population demanding enhanced medical care, are key growth factors. Innovations like recombinant thrombin have improved safety and efficacy, addressing concerns related to animal-derived products. Additionally, thrombin's expanding applications in biotechnology and pharmaceuticals, such as regenerative medicine and wound healing, contribute to market expansion. North America currently dominates this market due to its advanced healthcare system and favorable reimbursement policies, followed by Europe, while emerging markets in Asia, notably China and India, present significant growth potential. However, challenges such as high manufacturing costs, strict regulations, and competition from other hemostatic agents pose risks to market progression.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Thrombin market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Thrombin Market Segments Analysis

Global Thrombin Market is segmented by Product, Dosage Form, End-User and region. Based on Product, the market is segmented into Bovine Thrombin, Human Thrombin and Recombinant Thrombin. Based on Dosage Form, the market is segmented into Powder Form and Solution Form. Based on End-User, the market is segmented into Hospitals, Diagnostic Centers and Research Institutions. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Thrombin Market

The global thrombin market is driven by the rising number of surgical procedures, influenced by an aging population and the growing prevalence of non-communicable diseases such as cardiovascular conditions and cancer. With over 310 million surgeries conducted annually worldwide, the demand for thrombin-based products continues to soar, as thrombin is utilized in around 65% of cardiovascular surgeries and 55% of orthopedic procedures for local hemostasis. Additionally, the shift towards more minimally invasive surgical techniques necessitates effective hemostatic solutions like thrombin, which play a critical role in ensuring successful patient outcomes and enhancing overall surgical efficiency.

Restraints in the Global Thrombin Market

The global thrombin market faces significant constraints due to the high costs associated with thrombin production, particularly in the case of recombinant thrombin, which is a sophisticated biotechnological product. These elevated prices restrict its accessibility and application, particularly in healthcare facilities in developing regions where financial resources are limited. Consequently, many of these institutions may opt for more economical hemostatic alternatives, limiting the expansion and utilization of thrombin products in these markets. The high production costs thus pose a barrier to broader market penetration, hindering the integration of advanced hemostatic solutions in economically challenged healthcare settings.

Market Trends of the Global Thrombin Market

The Global Thrombin market is witnessing a notable shift towards the adoption of recombinant thrombin products, driven by their superior safety, purity, and consistency compared to traditional bovine-derived alternatives. This trend is fueled by the increasing emphasis on patient safety and the demand for effective hemostatic agents in surgical procedures. Additionally, the rise of minimally invasive surgical techniques necessitates reliable hemostasis, further propelling the utilization of advanced thrombin solutions. As healthcare providers seek to enhance procedural outcomes while minimizing complications, the preference for recombinant thrombin products is set to gain momentum, shaping the future landscape of the thrombin market.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies
Customer Buying Behavior Analysis

Global Thrombin Market Size by Product & CAGR (2025-2032)

Market Overview
Bovine Thrombin
Human Thrombin
Recombinant Thrombin

Global Thrombin Market Size by Dosage Form & CAGR (2025-2032)

Market Overview
Powder Form
Solution Form

Global Thrombin Market Size by End-User & CAGR (2025-2032)

Market Overview
Hospitals
Diagnostic Centers
Research Institutions

Global Thrombin Market Size & CAGR (2025-2032)

North America (Product, Dosage Form, End-User)
- US
- Canada
Europe (Product, Dosage Form, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Dosage Form, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Dosage Form, End-User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Dosage Form, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Pfizer Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson Services Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Baxter International Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shanghai RAAS Blood Products Co. Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CSL Behring
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Grifols
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hualan Biological Engineering
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Haematologic Technologies Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Octapharma AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Omrix Biopharmaceuticals Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Japan Blood Products Organization
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mallinckrodt Pharmaceuticals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mochida Pharmaceutical Co. Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

トロンビン市場規模、シェア、成長分析、製品別、剤形別、エンドユーザー別、地域別-2025年～2032年産業予測

Thrombin Market Size, Share, and Growth Analysis, By Product (Bovine Thrombin, Human Thrombin), By Dosage Form (Powder Form, Solution Form), By End-User, By Region - Industry Forecast 2025-2032

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

トロンビン市場規模：製品別& CAGR（2025年～2032年）

トロンビン市場規模：剤形別& CAGR（2025年～2032年）

トロンビン市場規模：エンドユーザー別& CAGR（2025年～2032年）

トロンビン市場規模& CAGR（2025年～2032年）